Changing Trends in Prevalence and Antibiotics Resistance of Uropathogens in Patients Attending the Gondar University Hospital, Northwest Ethiopia. (10th March 2014)

• Record Type: Journal Article
• Authors: Tiruneh, Moges; Yifru, Sisay; Gizachew, Mucheye; Molla, Kassie; Belyhun, Yeshambel; Moges, Feleke; Endris, Mengistu
• Other Names: D'Souza Doris H. Academic Editor.
• Is Part Of: International journal of bacteriology. Volume 2014(2014)
• Publication Date: 2014-03-10
• Subjects: Bacteriology -- Periodicals; Bacterial Physiological Phenomena; Bacteriology; Periodical; Periodicals; Fulltext; Internet Resources; Periodicals; Electronic journals; 616.9201
• DOI: 10.1155/2014/629424
• Languages: English
• ISSNs: 2356-6957

Abstract

Abstract : Background . In most hospitals of developing countries, urinary tract infections are treated empirically because of lack of culture facilities. This leads to emergence of multiresistant uropathogens. Culturing and drug susceptibility testing are essential to guide therapy. Objectives . To assess changing prevalence and resistance pattern of uropathogens to commonly used antibiotics in a two-year study period. Methods . Urine specimens were collected and cultured. Uropathogens were identified by standard methods and tested for antibiotics resistance. Data were analyzed using SPSS version 16 statistical sofware. P value < 0.05 was considered statistically significant. Results . The commonest isolates in both the previous and present studies were E. coli, Klebsiella, CoNS, S. aureus, Proteus, and Citrobacter species. Previous isolates of Enterobacteriaceae were 100% sensitive to ciprofloxacin, whereas present isolates developed 31% to 60% resistance to it. Previous isolates were less resistant to gentamycin than the present ones. Multiresistance isolates were predominant in present study than previous ones. Conclusion . E. coli was predominant in the two study periods. Present isolates were more resistant than previous ones. Some previous isolates were 100% sensitive to ciprofloxacin, whereas present isolates were increasingly resistant. Ciprofloxacin and gentamicin have been recommended for empiric treatment of urinary tract infections.